Emerald Health also recently acquired
Agro-Biotech, a Licensed Producer in
Saint-Eustache, Québec, and Health
Canada has approved a modular expan-
sion project, on a 32-acre site in Metro-
Vancouver, for a 500,000-square-foot
hybrid indoor and greenhouse growing
space, with expansion potential to one
million square feet.
Being at the forefront of a new industry
is a big undertaking. “We have big plans
to create a world leader in cannabis
science and to get there takes incredible
focus and energy,” says Hill. “Everyone
at Emerald—from the people in our grow
facilities, to post harvest production,
sales and marketing, our accountants,
HR teams, Quality Assurance, R&D and
new product development are working
at levels they’ve never before been asked
to. But it’s so very worth the effort. We
are in the very early days of this new and
exciting industry and we truly believe
in the potential benefits of the canna-
bis plants. The hundreds of stories I’ve
heard from people who use cannabis to
find relief previously unobtainable from
traditional medications are uplifting
and compel us all to push forward with
urgency.”
Emerald will continue to capitalize on the
enormous opportunities that lie ahead
by building on the momentum it has
created in Canada through our expand-
ing supply chain capacity with Pure
Sunfarms, Verdelite (our Quebec based
indoor grow and processing facility),
outdoor grow, and finalize its expansive
relationship with Factors Group, which
gives us industrial-scale extraction,
encapsulation, packaging, and distribu-
tion capabilities. Says Hill, “We will feed
this processing capability with supply
from PSF, Quebec, and outdoor grow,
including hemp to create value-added
products that will give people the confi-
dence to consume cannabis products
knowing that the outcome and their
desired effect is going to be consistent
every time.”
APRIL 2019 | BUSINESS ELITE CANADA 11
